Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer’s Disease: A Focus on Aducanumab and LecanemabMingchao Shi, Jie Zhu|Frontiers in Aging Neuroscience|2022Cited by 257
Peripheral blood amyloid-β involved in the pathogenesis of Alzheimer’s disease via impacting on peripheral innate immune cellsMingchao Shi, Jie Zhu|Journal of Neuroinflammation|2024Cited by 43